Michael Krebs
Chief Executive Officer at Heartbeat.bio AG
Michael Krebs active positions
| Companies | Position | Start | End |
|---|---|---|---|
Privatbank Von Graffenried AG
 Privatbank Von Graffenried AG Investment ManagersFinance Part of Von Graffenried Holding AG, Privatbank Von Graffenried AG is a Swiss company that provides investment advice. The company is based in Bern, Switzerland. The company was founded in 1979. Marcel Eggimann has been the CEO of the company since 1996. | Portfolio Manager-Equities | 31/12/2007 | - |
Heartbeat.bio AG
 Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Chief Executive Officer | - | - |
| Founder | - | - |
Career history of Michael Krebs
Statistics
International
| Switzerland | 2 |
| Austria | 2 |
Operational
| Portfolio Manager-Equities | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Finance | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Privatbank Von Graffenried AG
Privatbank Von Graffenried AG Investment ManagersFinance Part of Von Graffenried Holding AG, Privatbank Von Graffenried AG is a Swiss company that provides investment advice. The company is based in Bern, Switzerland. The company was founded in 1979. Marcel Eggimann has been the CEO of the company since 1996. | Finance |
Heartbeat.bio AG
Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Michael Krebs
- Experience
